[KJ-TFC-005] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Clinical trial NCT07662759 · RECRUITING

Trial details

NCT number: NCT07662759
Sponsor: Kukje Pharma
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Glaucoma Open-Angle Primary Ocular Hypertension

Start date: 2025-12-09
Primary completion: 2027-03-01
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.